-
No too long ago United Healthcare put out an oncology report and the questioning of the use of Avastin and it was mentioned as an area where they felt guidelines for their recommended treatment were not followed according to the data house on informational statistics. It is fairly expensive...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
06-07-2010
Filed under:
Filed under: Insurance, Pharma/FDA News, Biotech, Cancer, Oncology, Roche, ovarian cancer, Treatment, United HealthCare, brain cancer, healthcare reform, Genetech, Avatstin
-
It is finally beginning to take place, looking to see where there are possible duplicated efforts as well as trying to determine whether perhaps a device or a drug is the best answer for certain treatments and of course, cost is right in there. One good example in the text below is the treatment...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
07-05-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Medical Devices, Pharma, Biotech, Cancer, Hospitals, Treatment, Obama Healthcare, heart illness
-
About 6 months ago I had the opportunity to speak with Rosetta and some of the genomic testing they are doing, pretty amazing stuff especially with the test of being able to detect cancer of the unknown with lung tumors. This will bring a great treatment opportunity to many as sometimes cancer...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
06-19-2009
Filed under:
Filed under: Medically Related, Technology, personalized medicine, Genomics, Biotech, Cancer, Colon cancer, Cancer Treatment, Lung Cancer, Rosetta, microRNA, green, microarray, Cancer Tests
-
This is indeed a strange side effect, and obviously he might have trouble with biometric devices for logging on with a fingerprint too. Now he will need to carry a letter stating the reason for the lack of prints from his doctor. This had to be a new one for airport security here in the US...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
05-27-2009
Filed under:
Filed under: Medically Related, Technology, Other Items of Interest, healthcare, Biotech, Cancer, Security, Oncology, Chemotherapy, Side Effects, Fingerprints
-
This is somewhat sad that the funds are not rolling in here, thus the sale of the their lab. Back a few months ago I had the opportunity to interview Ronen Tamir, Chief Commercialization Officer from Rosetta after the recent purchase. You can read more at the link below, and I don’t think...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
05-24-2009
Filed under:
Filed under: Medically Related, Technology, personalized medicine, Genomics, Biotech, Cancer, Cancer Treatment, Lung Cancer, Rosetta, microRNA, green, microarray, Cancer Tests, Journal of Clinical Oncology
-
There’s quite a bit going on this week, and one expo in particular is the Annual Bio-IT Conference. Today, Microsoft announced Amalga Life Sciences Software. The press release and early adapters follows below. Additional Information can be read at the Bio-IT website. Yesterday, the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
04-28-2009
Filed under:
Filed under: Medically Related, Technology, Microsoft/Windows News, Genomics, healthcare, Biotech, Cancer, clinical trials, Science, Biology, Business Intelligence, Amalga, Life Sciences, Computer Science, Micosoft, Trento Centre
-
This is good news in finding cancer of the unknown with lung tumors. Back in January I have the opportunity to interview Rosetta about the tests and here’s a brief portion of the interview, use the link to read the entire post with all the details. The tests are 96% and thousand of patients...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
03-11-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, personalized medicine, Genomics, Biotech, Cancer, Cancer Treatment, Lung Cancer, Rosetta, microRNA, green, microarray, Cancer Tests, Journal of Clinical Oncology
-
October is the planned date to open the Smilow Cancer Hospital at Yale-New Haven, 500,000 square-foot, 14-story hospital. Genomic studies and sequencing are right in the plan. The facility will use molecular profiling to match therapy to the genetic signature of the patient’s tumor. ...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
02-26-2009
Filed under:
Filed under: Medically Related, Other Items of Interest, personalized medicine, Genomics, Biotech, Cancer, Colon cancer, Cancer Treatment, Sequencing, Lung Cancer, Yale University, microRNA, microarray, Cancer Tests, Harvard Medical Center, Thomas Lynch, Jr
-
Stem Cells are truly miraculous with what can be done with some diseases and health problems becoming a-symptomatic after the procedure. This procedures was actually very risky and one physician said 1/3 of the patients could die from the procedure as it is shutting down the immune system with...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
02-11-2009
Filed under:
Filed under: Medically Related, Technology, Other Items of Interest, healthcare, Biotech, Cancer, clinical trials, R and D, Stem Cells, Transplant, Blood Cells, HIV
-
A couple weeks ago I had the opportunity to interview Ronen Tamir, Chief Commercialization Officer, at Rosetta regarding their recently released tests for tumors found in lung cancer to identify cancer of the unknown primary. Just as with the lung cancer tests, the company is using microRNA biomarkers...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-17-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, personalized medicine, Genomics, Biotech, Cancer, Colon cancer, Cancer Treatment, Lung Cancer, Rosetta, microRNA, green, microarray, Cancer Tests
-
If you read my interview with Rosetta earlier this week, you will know how important these tests are in diagnosing “cancer of the unknown primary” with lung cancer tumors. In case you missed it, here’s the link below: Rosetta Genomics Interview – microRNA for Diagnosing Lung Cancer Tumors Rosetta...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-09-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, personalized medicine, Genomics, Biotech, Cancer, Cancer Treatment, Lung Cancer, Teva, Rosetta, microRNA, green, microarray, Cancer Tests
-
The company offers test for markers for cancer treatment for both lung and colon cancer to help determine which treatment plans will benefit the patient. The use of genetic testing is getting very specific as well as the tests and expressions. “RGI has determined ranges of ERCC1 expression...
-
Tests to detect cancer of the unknown primary Rosetta Genomics – Today I had the opportunity to speak with and interview Ronen Tamir, Chief Commercialization Officer, at Rosetta to find out how microRNA is helping diagnose and treat cancer. If you have been keeping up with the news of late...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-08-2009
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, Genomics, Biotech, Cancer, Cancer Treatment, Lung Cancer, Rosetta, microRNA, green, microarray, Cancer Tests
-
Well this might end up being a good move here as there’s much to gain. At least invest in something that has the potential to improve and save lives rather than to over deluge us with more social software. Don’t misunderstand here, I use and like social medias and it works well for me with...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-06-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, personalized medicine, healthcare, Biotech, Cancer, R and D, Start Ups, Venture Capital, Web 2.0
-
The product can locate cancer-associated proteins in a blood serum sample in less than an hour, and with much greater sensitivity than existing commercial devices. It detects multiple proteins at one time too, and by detecting multiple biomarkers simultaneously doctors may be able to be specific...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-04-2008
Filed under:
Filed under: Medically Related, Technology, healthcare, Biotech, Cancer, Blood Tests, R and D, Biomarkers, Stanford University, Molecular Science, markers